Loss of the von Hippel Lindau (VHL) tumor suppressor gene, a typical mutation found in most RCC patients that will be discussed below, seems to promote the pathological roles of NF-κB [29]. This evidence concerns the gene NFKB1 and renal cell adenocarcinoma.